Group was able to grow continuously revenue from rent and service business, which was recurring income, despite the negative impact on both economic and the COVID-19 pandemic. Revenue from rent and
% -20.4% Cost of rental and rendering of services 1/ 72.1 75.3 73.3 +1.6% -2.7% Cost of sales and services 1,363.9 1,485.6 1,195.8 -12.3% -19.5% Gross profit 1,062.1 1,070.6 1,015.3 -4.4% -5.2% Other income
with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000
subsidiary 3.19 0.85% - 0.00% 100.00 Other Income 4.33 1.16% 1.32 0.40% 227.34% Total Revenues 372.95 100.00% 334.57 100.00% 11.47% REVENUES For period 12 Month FOR THE YEAR ENDED 30 Jun 20 (Million Baht
than 87 percent and total sales and service income decreased by 30 percent. Gross profit increased by 319 percent. However, there is a positive impact on the overall operating results because in the past
(complex return fund); (d) investment units of a mutual fund of which the fund's net exposure in commodities is made through its investment in commodity-linked derivatives or instruments; (e) investment
per share, totaling approximately Baht 2,960.38 Million. The proposed dividend paid from profit with 23% and 20% Corporate Income Tax, can be credited in accordance with Section 47 bis of the Revenue
348.47 Costs of sales 184.91 217.85 263.12 Selling expenses 12.95 23.48 25.56 Administrative expenses 21.95 28.80 27.60 Finance costs 19.62 20.32 17.36 Profit before income tax 12.82 51.01 14.83 Income tax
141 ยูนิต 36 ยูนิต 2.มูลคำโครงกำร โดยวิธีวิเครำะหมูลคำจำกตนทุน (Cost Approach) 228,447,600 บำท โดยวิธีรำยได (Income Approach) 397,954,855.72 บำท โดยวิธีวิเครำะหมูลคำจำกตนทุน (Cost Approach) 62,663,815